APA (7th ed.) Citation

Nomura S, Shouzu A, Taniura T, Okuda Y, Omoto S, Suzuki M, . . . Toyoda N. (2023). Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus. Dove Medical Press.

Chicago Style (17th ed.) Citation

Nomura S, Shouzu A, Taniura T, Okuda Y, Omoto S, Suzuki M, Ito T, and Toyoda N. Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus. Dove Medical Press, 2023.

MLA (9th ed.) Citation

Nomura S, et al. Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus. Dove Medical Press, 2023.